Benitec Biopharma Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Benitec Biopharma Inc. (BNTC) had Lessee, Operating Lease, Liability, to be Paid, Year One of $387.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-05-14
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $387.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $512.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $100.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $145.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-03-31 | $387.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $512.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $145.00K 10-K/A · filed 2026-03-20 |
| 2024-06-30 | $291.00K 10-K · filed 2024-09-26 |
| 2024-03-31 | $74.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $147.00K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $221.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $295.00K 10-K · filed 2023-09-21 |
| 2023-03-31 | $292.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $289.00K 10-Q · filed 2023-02-13 |
| 2022-09-30 | $214.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $285.00K 10-K · filed 2022-09-02 |
| 2022-03-31 | $292.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $290.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $287.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $218.00K 10-K · filed 2021-09-20 |
| 2021-03-31 | $52.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $105.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $156.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $207.00K 10-K · filed 2020-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |